Announcement of Clinical Advisory Board

hemotune is excited to announce the assembly and first meeting of its Clinical Advisory Board. The board consists of highly recognized experts in sepsis, critical care, clinical research and immunology.

Lukas Langenegger, CEO and co-founder of hemotune AG, states: “We are very happy and proud to welcome world leaders in sepsis and critical care to our Clinical Advisory Board. Together we share the vision to reduce the burden of sepsis by bringing cutting edge technology to medical experts and patients in need.”

If you are interested to learn more about the experts in our Clinical Advisory Board you can browse the attached announcement.

Hemotune announces Clinical Advisory Board - Sept 2021

.pdf

Download PDF • 104KB